Inhibrx Biosciences (INBX) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 28, 2025, to be held virtually for stockholders of record as of April 1, 2025.

• Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K, are available online, with paper copies available upon request.

Voting matters and shareholder proposals

• Election of two Class I directors to serve until the 2028 Annual Meeting or until successors are elected and qualified.

• Ratification of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025.

• Board recommends a vote FOR both proposals.

• Other business may be transacted as may properly come before the meeting.

Board of directors and corporate governance

• Nominees for Class I director positions are Jon Faiz Kayyem, Ph.D., and Kristiina Vuori, M.D., Ph.D.